Assessment of the Organ-dose Reduction and Secondary Cancer Risk Associated With the Use of Proton Beam Therapy and Intensity Modulated Radiation Therapy in Treatment of Neuroblastoma
Hiroshi Fuji, T. Nishimura(Shizuoka Cancer Center), Uwe Schneider(University of Zurich), Hideomi Yamashita(University of Tokyo Hospital), Hiroyuki Asakura(Tokyo Metropolitan Institute of Public Health), Masayoshi KONNO(Shizuoka Cancer Center), Yasuaki Ishida(Shizuoka Cancer Center), Yuki Kase(Yokogawa Electric (Japan)), S. Murayama(Tokyo National Hospital), Hiroyuki Harada(Tokyo Medical and Dental University)
International Journal of Radiation Oncology*Biology*Physics
October 25, 2012
Cited by 0
Related Papers
Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion Beams
|Radiation Research|2006|353
Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model
|Physics in Medicine and Biology|2010|318
AAPM task group 224: Comprehensive proton therapy machine quality assurance
|Medical Physics|2019|228
Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation
|Physics in Medicine and Biology|2007|176